Phoremost: PhoreMost achieves milestone payment in discovery alliance with Boehringer Ingelheim
PhoreMost Ltd has triggered a second milestone payment in its multi─project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting
Read full article »
PhoreMost is an England-based biopharmaceutical company that develops phenotypic screening platforms and antibody-based therapies to treat infectious diseases.
Read more